Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Penumbra Denmark ApS
APS
Active
Advertising protection
CVR 43820702
Godthåbsvej 4, 8600
Silkeborg
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2023 · 3 years old
7 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Penumbra Denmark ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
4M
9M
13M
17M
3M
2023
15M
2024
EBITDA
DKK millions
1M
1M
1M
0M
0M
0M
2023
1M
+100%
2024
Income statement
DKK thousands
Item
2023
2024
Gross profit
2.882
14.510
Staff expenses
-2.701
-13.290
EBITDA
181
1.220
Depreciation & amort.
-0
-0
EBIT
181
1.220
Net financials
-0
-30
Profit before tax
181
1.190
Tax
63
289
Net profit
117
901
Balance sheet
DKK thousands
Item
2023
2024
Total assets
853
4.650
Equity
157
1.058
Long-term debt
0
0
Short-term debt
695
3.592
Total debt
695
3.592
Financial ratios
5-year trend
EBITDA margin (of gross profit)
8.4%
This company
2023
2024
Equity ratio
22.8%
This company
38.2%
Market median
-40% vs market
2023
2024
Return on equity
85.1%
This company
18.4%
Market median
+362% vs market
2023
2024
Net profit margin (of gross profit)
6.2%
This company
2023
2024
Asset turnover (of gross profit)
3.12×
This company
2023
2024
Debt / equity
3.39×
This company
0.62×
Market median
-447% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-31 – 2023-12-31
View
PDF
More on Penumbra Denmark ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
